APA (7th ed.) Citation

Shaymaa E. Kassab, Samar Mowafy, Aya M. Alserw, Joustin A. Seliem, Shahenda M. El-Naggar, Nesreen N. Omar, & Mohamed M. Awad. (2019). Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Shaymaa E. Kassab, Samar Mowafy, Aya M. Alserw, Joustin A. Seliem, Shahenda M. El-Naggar, Nesreen N. Omar, and Mohamed M. Awad. Structure-based Design Generated Novel Hydroxamic Acid Based Preferential HDAC6 Lead Inhibitor with On-target Cytotoxic Activity Against Primary Choroid Plexus Carcinoma. Taylor & Francis Group, 2019.

MLA (9th ed.) Citation

Shaymaa E. Kassab, et al. Structure-based Design Generated Novel Hydroxamic Acid Based Preferential HDAC6 Lead Inhibitor with On-target Cytotoxic Activity Against Primary Choroid Plexus Carcinoma. Taylor & Francis Group, 2019.